Xin Lang Cai Jing·2025-11-27 01:24Group 1 - The core viewpoint of the news is that Spring Medical has shown significant financial performance with a notable increase in revenue and net profit, indicating strong growth potential in the orthopedic medical device sector [2][3] - As of September 30, 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a remarkable increase of 213.21% [2] - The company has a high financing balance of 40.53 million yuan, which accounts for 0.57% of its market capitalization, indicating a strong interest from investors [1] Group 2 - Spring Medical's main business involves the research, production, and sales of implantable orthopedic medical devices, with its primary products including joint prosthetics and spinal implants [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2]